{Reference Type}: Journal Article
{Title}: Rare severe constrictive pericarditis complication in Erdheim-Chester disease: A case report and literature review.
{Author}: Miyazaki T;Kamimura D;Wakamatsu M;Konishi M;Matsumura A;Teshigawara H;Teranaka H;Koyama S;Takahashi H;Kunimoto H;Enaka M;Hagihara M;Matsumoto K;Yamazaki E;Nakajima H;
{Journal}: J Clin Exp Hematop
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 31
暂无{DOI}: 10.3960/jslrt.24006
{Abstract}: Erdheim-Chester disease (ECD) is a rare, non-Langerhans cell histiocytosis with diverse clinical features. It is characterized by systemic histiocyte infiltration of the bone, skin, central nervous system, lung, kidney, and cardiovascular system. Pericardial involvement is frequently revealed through either pericardial effusion or pericardial thickening in patients with ECD. Although most patients remain asymptomatic, progressive pericarditis, effusion, or cardiac tamponade may occur. Herein, we report a rare and unusual presentation of ECD in a 51-year-old man who experienced severe constrictive pericarditis. The patient presented with uncontrolled fluid retention and heart failure. After the diagnosis of ECD, interferon alpha treatment was administered. The patient recovered dramatically with decreased pleural and pericardial effusion, as well as improvements in the echocardiographic signs of constrictive pericarditis. Despite several therapeutic options described in the literature for managing ECD-related pericardial disease, a standard treatment has not been established. This report highlights the importance of early treatment based on accurate diagnosis of an unusual ECD complication.